Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MTOR PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MTOR PATHWAY |
| Key Genes/Proteins | ACSL4, AKT, AMPK, AMYLOID, APOE, APP |
| Related Diseases | AGING, ALZHEIMER'S DISEASE, AUTOPHAGY, BREAST CANCER |
graph TD
MTOR_PATHWAY["MTOR PATHWAY"]
MTOR_PATHWAY -->|"inhibits"| autophagy["autophagy"]
MTOR_PATHWAY -->|"mediates"| Offspring_Stem_Cell_Programmin["Offspring Stem Cell Programming"]
MTOR_PATHWAY -->|"activates"| Vascular_Niche_Formation["Vascular Niche Formation"]
MTOR_PATHWAY -->|"regulates"| Autophagy["Autophagy"]
MTOR_PATHWAY -->|"causes"| epilepsy["epilepsy"]
MTOR_PATHWAY -->|"contributes to"| neuronal_excitability["neuronal excitability"]
MTOR_PATHWAY -->|"involved_in"| Salidroside_Induced_Cell_Death["Salidroside-Induced Cell Death"]
AKT["AKT"] -->|"upstream_of"| MTOR_PATHWAY
Lyso_ChR2["Lyso-ChR2"] -->|"activates"| MTOR_PATHWAY
PI3K_AKT_pathway["PI3K-AKT pathway"] -->|"interacts"| MTOR_PATHWAY
Hearing_Loss["Hearing Loss"] -->|"activates"| MTOR_PATHWAY
Short_Chain_Fatty_Acids["Short-Chain Fatty Acids"] -->|"activates"| MTOR_PATHWAY
Ferroptosis["Ferroptosis"] -->|"involved_in"| MTOR_PATHWAY
MTOR["MTOR"] -->|"activates"| MTOR_PATHWAY
CANCER["CANCER"] -->|"activates"| MTOR_PATHWAY| Target | Relation | Type | Str |
|---|---|---|---|
| Offspring Stem Cell Programming | mediates | process | 0.90 |
| autophagy | inhibits | pathway | 0.90 |
| Vascular Niche Formation | activates | process | 0.85 |
| Cancer | associated_with | disease | 0.85 |
| Type 2 Diabetes | associated_with | disease | 0.85 |
| Autophagy | regulates | process | 0.85 |
| Autophagy | regulates | pathway | 0.80 |
| Salidroside-Induced Cell Death | involved_in | mechanism | 0.80 |
| epilepsy | causes | disease | 0.80 |
| neuronal excitability | contributes_to | phenotype | 0.80 |
| Autophagy | modulates | process | 0.80 |
| Amyloid-Beta | regulates | protein | 0.80 |
| Perivascular Neuroprotection | associated_with | process | 0.75 |
| ageing | regulates | process | 0.70 |
| protein function | modulates | process | 0.70 |
| AGING | regulates | phenotype | 0.65 |
| AUTOPHAGY | treats | phenotype | 0.65 |
| CELL DEATH | activates | phenotype | 0.65 |
| INFLAMMATION | regulates | phenotype | 0.65 |
| AGING | targets | phenotype | 0.65 |
| PIK3CA | regulates | gene | 0.65 |
| AGING | treats | phenotype | 0.65 |
| BREAST CANCER | inhibits | disease | 0.65 |
| REMYELINATION | implicated_in | phenotype | 0.55 |
| AMYLOID | associated_with | protein | 0.50 |
| APOE | associated_with | gene | 0.50 |
| TFEB | associated_with | gene | 0.50 |
| LDLR | associated_with | gene | 0.50 |
| APP | associated_with | gene | 0.50 |
| TAU | associated_with | protein | 0.50 |
| TNF | associated_with | gene | 0.50 |
| HK2 | associated_with | gene | 0.50 |
| MITOPHAGY | associated_with | phenotype | 0.50 |
| PARKIN | associated_with | gene | 0.50 |
| TREM2 | associated_with | gene | 0.50 |
| PINK1 | associated_with | gene | 0.50 |
| OBESITY | associated_with | disease | 0.45 |
| EGFR | associated_with | gene | 0.45 |
| DIABETES | associated_with | disease | 0.45 |
| IDH1 | associated_with | gene | 0.45 |
| QUERCETIN | associated_with | drug | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| VEGF | associated_with | gene | 0.45 |
| VEGFA | associated_with | gene | 0.45 |
| SENESCENCE | associated_with | phenotype | 0.45 |
| SARCOPENIA | associated_with | disease | 0.45 |
| TDP-43 | associated_with | protein | 0.45 |
| BAICALEIN | associated_with | drug | 0.45 |
| GLYCOLYSIS | associated_with | phenotype | 0.45 |
| TH | associated_with | gene | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOE4 | activates | gene | 0.90 |
| 41545347 | activates | paper | 0.90 |
| AKT | upstream_of | protein | 0.90 |
| Lyso-ChR2 | activates | protein | 0.88 |
| PI3K-AKT pathway | interacts_with | pathway | 0.85 |
| Hearing Loss | activates | phenotype | 0.85 |
| Short-Chain Fatty Acids | activates | compound | 0.80 |
| Ferroptosis | involved_in | process | 0.75 |
| CANCER | targets | disease | 0.65 |
| RAPAMYCIN | treats | drug | 0.65 |
| APOE | inhibits | gene | 0.55 |
| P2RY12 | inhibits | gene | 0.55 |
| NLRP3 | involved_in | gene | 0.55 |
| SIRT3 | involved_in | gene | 0.55 |
| PRMT1 | inhibits | gene | 0.55 |
| GJA1 | activates | gene | 0.55 |
| GJA1 | involved_in | gene | 0.55 |
| LAMP1 | activates | gene | 0.55 |
| PPARGC1A | activates | gene | 0.55 |
| RAB7A | activates | gene | 0.55 |
| ULK1 | expression | gene | 0.55 |
| FKBP5 | inhibits | gene | 0.55 |
| SNCA | neuroprotective | gene | 0.55 |
| TREM2 | involved_in | gene | 0.55 |
| FKBP5 | activates | gene | 0.55 |
| GFAP | activates | gene | 0.55 |
| LAMP1 | inhibits | gene | 0.55 |
| MCOLN1 | inhibits | gene | 0.55 |
| NLRP3 | neuroprotective | gene | 0.55 |
| SIRT3 | neuroprotective | gene | 0.55 |
| ULK1 | involved_in | gene | 0.55 |
| ULK1 | inhibits | gene | 0.55 |
| MMP9 | inhibits | gene | 0.55 |
| STING1 | interacts_with | gene | 0.55 |
| STING1 | involved_in | gene | 0.55 |
| STING1 | regulates | gene | 0.55 |
| C1Q | activates | gene | 0.55 |
| FOXO1 | activates | gene | 0.55 |
| GLP1R | activates | gene | 0.55 |
| PLIN2 | activates | gene | 0.55 |
| SIRT3 | activates | gene | 0.55 |
| SREBF2 | activates | gene | 0.55 |
| CHR2 | activates | gene | 0.55 |
| BDNF | interacts_with | gene | 0.55 |
| SNAP25 | inhibits | gene | 0.55 |
| ACSL4 | modifies | gene | 0.55 |
| GPX4 | modifies | gene | 0.55 |
| SLC7A11 | modifies | gene | 0.55 |
| BDNF | activates | gene | 0.55 |
| TFAM | inhibits | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-08 | 1 hypotheses Top: 0.280
neurodegeneration | 2026-04-01 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-10
closed · Rounds: 5 · Score: 0.94 · 2026-04-01
Hypotheses and analyses mentioning MTOR PATHWAY in their description or question text
No additional research found